Cancer · 1982 · 13 citations · 14 references
MedicineEndocrinologyPathologyCarcinogenesisEndocrine OncologyNeoplasiaBreast PathologyEndocrine Tumor PathologyHormone-secreting TumorsMammary TumorsPituitary DisordersPituitary TumorsBenign Breast Entity RecognitionBenign Breast NeoplasmsBenign Breast TumorsBreast HyperplasiaLaboratory EvidenceMalignant Breast TumorsPituitary Adenoma EndocrinologyPituitary Tumor Pathogenesis
The histology of breast lumps in five patients with hyperprolactinemia showed benign mammary dysplasia with vacuolation of acinar and duct lining cells. In two cases, foci of lobular development resembling lactating breast tissue were also noted. In the past, focal secretory change has been considered to be idiopathic, but these cases indicate a possible association with hyperprolactinemia. Among other causes hyperprolactinemia may be a manifestation of occult pituitary adenoma. Therefore it is suggested that patients with benign breast nodules showing focal secretory change should be screened for clinical and laboratory evidence of hyperprolactinemia. Although it is accepted that in mice and rats prolactin plays an important role in chemically induced mammary tumorigenesis, a consensus has not been reached with regard to its role in man.
14
S. R. Wellings, Hanne M. Jensen, R. G. Marcum · JNCI Journal of the National Cancer Institute · 1975 · 753 citations
Progress in Clinical and Biological Research
A L Crombie · British Journal of Ophthalmology · 1989 · 553 citations · Full text
Prolactin and murine mammary tumorigenesis: a review.
Clifford W. Welsch, Hiroshi Nagasawa · PubMed · 1977 · 465 citations
Medicine, Endocrinology, Oncology +17
Prognostic Factors in Breast Cancer.
Archives of Internal Medicine · 1969 · 343 citations
Medicine, Cancer Biology, Oncology +16